← Back to Search

Distress Screening + Consultation for Cancer Caregivers

N/A

Waitlist Available

Led By Allison Applebaum, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial will compare the effectiveness of two types of treatments for people with bladder cancer that has spread to the muscle of the bladder wall.

Who is the study for?

This trial is for English-speaking adults who identify as caregivers to cancer patients undergoing surgery or treatment at specified hospital locations. They must be able to fulfill caregiver responsibilities during the perioperative phases and not have cognitive difficulties or severe medical illnesses that could interfere with participation.Check my eligibility

What is being tested?

The study compares two approaches: Distress Screening + Consultation (S+C) versus Enhanced Usual Care (EUC) for caregivers of cancer patients. It aims to determine if S+C offers any benefits over EUC in managing caregiver distress.See study design

What are the potential side effects?

Since this trial involves psychological screening and consultation rather than medication, traditional physical side effects are not applicable. However, participants may experience emotional discomfort when discussing personal issues related to caregiving.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Informal caregivers with unmet needs

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CancerSupportSource-CG screening plus consultation (S+C)Experimental Treatment5 Interventions

ICs randomized to S+C will complete the web-based CSS-CG (Appendix C) using a tablet immediately following baseline study measures. In case of technical issues, ICs may complete Appendix C with the guidance of a member of the research study team. The CSS-CG asks ICs to rate their level of concern for 33 different possible problems: if a need is rated as low (i.e., "A little" or less concern), after each problem is rated ICs will be prompted to request pertinent educational materials if they are interested. If a need is endorsed (i.e., "Moderate" or greater concern), ICs are asked through the web-based electronic platform (https://mskcc.mycarereport.com) whether they would like educational materials and/or to speak with someone about that need (i.e., receive a referral).

Group II: Enhanced usual care (EUC)Active Control4 Interventions

ICs randomized to EUC following baseline questionnaire completion will be given instructions (Appendix I) on how to access or create an account to access the myMSK online portal IC Resources page (https://my.mskcc.org/login). If the caregiver does not wish to enroll in MyMSK, the research study staff will send them an email with sample referral material ( Appendix D. The IC Resources page includes links to extant MSK educational materials for ICs (e.g., "A Guide for Caregivers" [47]), contact information for psychosocial services (e.g., Caregivers Clinic in the MSK Counseling Center), and external resources (e.g., educational materials and services through the CSC, American Cancer Society, and others) (Appendix D,).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,470 Total Patients Enrolled

University of VirginiaOTHER

753 Previous Clinical Trials

1,244,881 Total Patients Enrolled

Allison Applebaum, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

7 Previous Clinical Trials

926 Total Patients Enrolled

Media Library

CSS-CG Clinical Trial Eligibility Overview. Trial Name: NCT03856086 — N/A

Cancer Caregivers Research Study Groups: CancerSupportSource-CG screening plus consultation (S+C), Enhanced usual care (EUC)

Cancer Caregivers Clinical Trial 2023: CSS-CG Highlights & Side Effects. Trial Name: NCT03856086 — N/A

CSS-CG 2023 Treatment Timeline for Medical Study. Trial Name: NCT03856086 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available spots for those interested in participating in this clinical trial?

"As reported on clinicaltrials.gov, recruitment for this trial has ceased - the initial posting was made on February 25th 2019 and the last update date was November 23rd 2022. However, there are presently two other medical trials that require participants to enrol."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients

2019. "Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03856086.